Cargando…

Complicated skin and soft tissue infections: literature review of evidence for and experience with daptomycin

Skin and soft tissue infections (SSTIs) are the second most common infection encountered in hospitals. Management decisions have become increasingly complex due to the prevalence of resistant pathogens, the wide array of licensed antimicrobials and the availability of potent oral agents and of out-p...

Descripción completa

Detalles Bibliográficos
Autores principales:	White, Beth, Seaton, R Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132872/ https://www.ncbi.nlm.nih.gov/pubmed/21753891 http://dx.doi.org/10.2147/IDR.S13808

Ejemplares similares

The impact of initial antibiotic therapy (linezolid, vancomycin, daptomycin) on hospital length of stay for complicated skin and soft tissue infections
por: Szczypinska, Ewa, et al.
Publicado: (2013)

Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections
por: Gonzalez-Ruiz, Armando, et al.
Publicado: (2016)

Efficacy and safety of intravenous daptomycin in Japanese patients with skin and soft tissue infections
por: Aikawa, Naoki, et al.
Publicado: (2012)

Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin
por: Eckmann, Christian, et al.
Publicado: (2010)

Efficacy and safety of daptomycin for skin and soft tissue infections: a systematic review with trial sequential analysis
por: Liu, Chao, et al.
Publicado: (2016)

A review of daptomycin for injection (Cubicin) in the treatment of complicated skin and skin structure infections
por: Shoemaker, D Matthew, et al.
Publicado: (2006)

Real-World Treatment of Complicated Skin and Soft Tissue Infections with Daptomycin: Results from a Large European Registry (EU-CORE)
por: Cogo, Alberto, et al.
Publicado: (2015)

Pharmacokinetics and skin-tissue penetration of daptomycin in rats
por: Matsumoto, Kazuaki, et al.
Publicado: (2015)

Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin
por: Stephens, Jennifer M, et al.
Publicado: (2013)

Comparative Efficacy and Safety of Vancomycin, Linezolid, Tedizolid, and Daptomycin in Treating Patients with Suspected or Proven Complicated Skin and Soft Tissue Infections: An Updated Network Meta-Analysis
por: Feng, Jingjuan, et al.
Publicado: (2021)

Clinical experience with daptomycin in Europe: the first 2.5 years
por: Gonzalez-Ruiz, Armando, et al.
Publicado: (2011)

The safety and efficacy of daptomycin versus other antibiotics for skin and soft-tissue infections: a meta-analysis of randomised controlled trials
por: Wang, Shou Zhen, et al.
Publicado: (2014)

In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates from skin and soft tissue infections to vancomycin, daptomycin, linezolid and tedizolid
por: Vanegas Múnera, Johanna Marcela, et al.
Publicado: (2017)

Dalbavancin in the treatment of complicated skin and soft-tissue infections: a review
por: Bennett, Jason W, et al.
Publicado: (2008)

Meropenem in the treatment of complicated skin and soft tissue infections
por: Fish, Douglas N
Publicado: (2006)

Daptomycin in bone and joint infections: a review of the literature
por: Rice, Dennis A. K., et al.
Publicado: (2008)

Tigecycline: an evidence-based review of its antibacterial activity and effectiveness in complicated skin and soft tissue and intraabdominal infections
por: Dunn, Christopher J.
Publicado: (2006)

Linezolid in the treatment of HIV-infected patients with complicated skin and soft tissue infections
por: Khachatryan, N, et al.
Publicado: (2007)

Complicated skin, skin structure and soft tissue infections - are we threatened by multi-resistant pathogens?
por: Kujath, P, et al.
Publicado: (2010)

Telavancin, a new lipoglycopeptide antimicrobial, in complicated skin and soft tissue infections
por: Jafari Saraf, Lida, et al.
Publicado: (2011)

Ceftaroline in the management of complicated skin and soft tissue infections and community acquired pneumonia
por: Mpenge, Mbiye A, et al.
Publicado: (2015)

Daptomycin: Local Application in Implant-Associated Infection and Complicated Osteomyelitis
por: Rosslenbroich, Steffen B., et al.
Publicado: (2012)

Daptomycin for the treatment of osteomyelitis and orthopaedic device infections: real-world clinical experience from a European registry
por: Malizos, K., et al.
Publicado: (2015)

Skin and soft tissue infections in the elderly
por: Falcone, Marco, et al.
Publicado: (2023)

Skin and Soft Tissue Infection due to Rapidly Growing Mycobacteria: Case Series and Literature Review
por: Yu, Jung Re, et al.
Publicado: (2013)

Evaluation of Effectiveness and Safety of High-Dose Daptomycin: Results from Patients Included in the European Cubicin(®) Outcomes Registry and Experience
por: Seaton, R. Andrew, et al.
Publicado: (2015)

Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infections
por: Das, Shampa, et al.
Publicado: (2019)

Complicated Posterior Cervical Skin and Soft Tissue Infections at a Single Referral Center
por: Zhao, Jing-Chun, et al.
Publicado: (2020)

Population Pharmacokinetics of Cefazolin in Serum and Tissue for Patients with Complicated Skin and Soft Tissue Infections (cSSTI)
por: So, Wonhee, et al.
Publicado: (2014)

A potential role for daptomycin in enterococcal infections: what is the evidence?
por: Cantón, Rafael, et al.
Publicado: (2010)

Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus
por: Storm, Jeremy C, et al.
Publicado: (2012)

Acid-fast bacteria as causative agents of skin and soft tissue infections: case presentations and literature review
por: Spiliopoulou, Anastasia, et al.
Publicado: (2023)

A literature review of microvascular proliferation in arteriovenous malformations of skin and soft tissue
por: Utami, Amalia Mulia, et al.
Publicado: (2021)

Daptomycin-induced Eosinophilic Pneumonia and a Review of the Published Literature
por: Higashi, Yoshitsugu, et al.
Publicado: (2017)

Daptomycin-Associated Diarrhea: A Case Report and Review of the Literature
por: Awadelkarim, Abdalaziz M, et al.
Publicado: (2022)

The skin and soft tissue infections in hematological patients
por: Ungaro, Riccardo, et al.
Publicado: (2020)

Retrospective Analysis of Clinical and Cost Outcomes Associated with Methicillin-Resistant Staphylococcus aureus Complicated Skin and Skin Structure Infections Treated with Daptomycin, Vancomycin, or Linezolid
por: Wright, Bradley M., et al.
Publicado: (2011)

An open-label, pragmatic, randomized controlled clinical trial to evaluate the comparative effectiveness of daptomycin versus vancomycin for the treatment of complicated skin and skin structure infection
por: Kauf, Teresa L., et al.
Publicado: (2015)

Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics
por: Leong, Hoe Nam, et al.
Publicado: (2018)

Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia
por: Esposito, Susanna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h862tnkbovmlmjsvaannl361lu